[1]
|
Caplin, M.E., Baudin, E., Ferolla, P., Filosso, P., Garcia-Yuste, M., Lim, E., et al. (2015) Pulmonary Neuroendocrine (Carcinoid) Tumors: European Neuroendocrine Tumor Society Expert Consensus and Recommendations for Best Practice for Typical and Atypical Pulmonary Carcinoids. Annals of Oncology, 26, 1604-1620. https://doi.org/10.1093/annonc/mdv041
|
[2]
|
Panzuto, F., Merola, E., Pavel, M.E., Rinke, A., Kump, P., Partelli, S., et al. (2017) Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome. The Oncologist, 22, 409-415. https://doi.org/10.1634/theoncologist.2016-0351
|
[3]
|
Rindi, G., Klersy, C., Albarello, L., Baudin, E., Bianchi, A., Buchler, M.W., et al. (2018) Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study. Neuroendocrinology, 107, 375-386. https://doi.org/10.1159/000494355
|
[4]
|
Cives, M. and Strosberg, J.R. (2018) Gastroenteropancreatic Neuroendocrine Tumors. CA: A Cancer Journal for Clinicians, 68, 471-487. https://doi.org/10.3322/caac.21493
|
[5]
|
Bulens, P., Thomas, M., Deroose, C.M. and Haustermans, K. (2018) PET Imaging in Adaptive Radiotherapy of Gastrointestinal Tumors. The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 62, 385-403. https://doi.org/10.23736/s1824-4785.18.03081-9
|
[6]
|
Opalinska, M., Hubalewska-Dydejczyk, A. and Sowa-Staszczak, A. (2017) Radiolabeled Peptides: Current and New Perspectives. The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 61, 153-167. https://doi.org/10.23736/s1824-4785.17.02971-5
|
[7]
|
Zeelen, C., Paus, C., Draper, D., Heskamp, S., Signore, A., Galli, F., et al. (2018) In vivo Imaging of Tumor-Infiltrating Immune Cells: Implications for Cancer Immunotherapy. The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 62, 56-77. https://doi.org/10.23736/s1824-4785.17.03052-7
|
[8]
|
Kunz, P.L., Reidy-Lagunes, D., Anthony, L.B., et al. (2013) Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors. Pancreas, 42, 557-577. https://doi.org/10.1097/MPA.0b013e31828e34a4
|
[9]
|
De Herder, W.W. and Capdevila, J. (2018) Unmet Needs in the Field of Neuroendocrine Neoplasms of the Gastrointestinal Tract, Pancreas, and Respiratory System: Reports by the ENETS Group. Neuroendocrinology, 108, 5-6. https://doi.org/10.1159/000495036
|
[10]
|
Forrest, L.M., McMillan, D.C., McArdle, C.S. and Dunlop, D.J. (2005) An Evaluation of the Impact of a Multidisciplinary Team, in a Single Centre, on Treatment and Survival in Patients with Inoperable Non-Small-Cell Lung Cancer. British Journal of Cancer, 93, 977-978. https://doi.org/10.1038/sj.bjc.6602825
|
[11]
|
Wright, F.C., De Vito, C., Langer, B. and Hunter, A. (2007) Multidisciplinary Cancer Conferences: A Systematic Review and Development of Practice Standards. European Journal of Cancer, 43, 1002-1010. https://doi.org/10.1016/j.ejca.2007.01.025
|
[12]
|
张雅婧, 陈飞帆, 张艺译, 等. 胰腺神经内分泌肿瘤的诊疗进展[J]. 现代消化及介入诊疗, 2021, 26(7): 925-928, 931.
|
[13]
|
吴文铭, 陈洁, 白春梅, 等. 中国胰腺神经内分泌肿瘤诊疗指南(2020) [J]. 协和医学杂志, 2021, 12(4): 460-480.
|
[14]
|
Sun, J. (2017) Pancreatic Neuroendocrine Tumors. Intractable & Rare Diseases Research, 6, 21-28. https://doi.org/10.5582/irdr.2017.01007
|
[15]
|
Magi, L., Mazzuca, F., Rinzivillo, M., Arrivi, G., Pilozzi, E., Prosperi, D., et al. (2019) Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral Center. Journal of Clinical Medicine, 8, Article 910. https://doi.org/10.3390/jcm8060910
|
[16]
|
Li, W., Miao, F., Xu, X., Zhang, J., Wu, Z., Chen, K., et al. (2021) Pancreatic Neuroendocrine Neoplasms: CT Spectral Imaging in Grading. Academic Radiology, 28, 208-216. https://doi.org/10.1016/j.acra.2020.01.033
|
[17]
|
Tawfik, K., Wisam, S., Pietro, F., et al. (2023) Safety and Efficacy of Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neuroendocrine Neoplasms: Systematic Review and Meta-Analysis. Digestive Endoscopy, 36, 395-405. https://doi.org/10.1111/den.14681
|
[18]
|
吴峻立, 苗毅. 胰腺神经内分泌肿瘤肝转移术前评估和外科治疗策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(1): 6-10.
|
[19]
|
Paik, W. and Lee, K. (2022) Management of Small Nonfunctioning Pancreatic Neuroendocrine Neoplasms: Current Opinion and Controversies. Journal of Clinical Medicine, 12, Article 251. https://doi.org/10.3390/jcm12010251
|
[20]
|
Magi, L., Marasco, M., Rinzivillo, M., Faggiano, A. and Panzuto, F. (2023) Management of Functional Pancreatic Neuroendocrine Neoplasms. Current Treatment Options in Oncology, 24, 725-741. https://doi.org/10.1007/s11864-023-01085-0
|
[21]
|
Yongzheng, L., Zhiyao, F., Feifei, Z., et al. (2022) Neoadjuvant Therapy in Pancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Frontiers in Oncology, 12, Article 981575. https://doi.org/10.3389/fonc.2022.981575
|
[22]
|
高鹤丽, 徐近, 陈洁, 等. 胰腺神经内分泌瘤的精准诊疗进展[J]. 中国癌症杂志, 2023, 33(11): 993-1001.
|
[23]
|
张梓桐, 詹峰. 胰腺神经内分泌肿瘤的非手术诊疗进展[J]. 中国普通外科杂志, 2023, 32(9): 1387-1395.
|
[24]
|
王先泽, 吴文铭. 胰腺神经内分泌肿瘤外科治疗理念的四种转变[J]. 中国癌症杂志, 2022, 32(9): 765-771.
|
[25]
|
孟煜凡, 杨健, 樊知遥, 等. 胰腺神经内分泌肿瘤微创手术治疗的争议与实践[J]. 腹腔镜外科杂志, 2021, 26(12): 885-889.
|
[26]
|
Bozena, S., Agapi, K., Julie, E., et al. (2022) Liquid Biopsy and Preclinical Tools for Advancing Diagnosis and Treatment of Patients with Pancreatic Neuroendocrine Neoplasms. Critical Reviews in Oncology/Hematology, 180, Article 103865. https://doi.org/10.1016/j.critrevonc.2022.103865
|
[27]
|
Ohmoto, A., Rokutan, H. and Yachida, S. (2017) Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future. International Journal of Molecular Sciences, 18, Article 143. https://doi.org/10.3390/ijms18010143
|
[28]
|
Simtniece, Z., Vanags, A., Strumfa, I., Sperga, M., Vasko, E., Prieditis, P., et al. (2015) Original Paper Morphological and Immunohistochemical Profile of Pancreatic Neuroendocrine Neoplasms. Polish Journal of Pathology, 2, 176-194. https://doi.org/10.5114/pjp.2015.53015
|
[29]
|
杨佳妮, 张海蓉. 胰腺神经内分泌肿瘤微环境的形成机制及免疫/靶向治疗研究进展[J]. 临床肝胆病杂志, 2023, 39(8): 2005-2011.
|